NCT01445379 2019-12-17Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed33 enrolled
NCT01986426 2018-10-03LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or PembrolizumabLytix Biopharma ASPhase 1 Completed80 enrolled
NCT00047164 2016-09-26Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed89 enrolled